title: Ketorolac induced acute reversible hearing loss in a patient maintained on CAPD.
authors.forename: T
authors.initials: T
authors.lastname: Otti
authors.forename: M
authors.initials: M
authors.lastname: Weindel
authors.forename: B
authors.initials: B
authors.lastname: Bastani
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D020910:Ketorolac; D007676:Kidney Failure, Chronic / Q000150:complications; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D014046:Tolmetin; D020910:Ketorolac